Blenrep (belantamab mafodotin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Blenrep (belantamab mafodotin), covering 2025-12-22 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma [Phase 2]